Abstract
BackgroundCTLA-4 is highly expressed on most regulatory T cells (Tregs) but only upregulated in effector T cells following activation. Emerging evidence suggests anti-tumor activity of antibodies targeting CTLA-4 may be...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have